U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir Business Wire (Press Release) 13:34
South Africa: Who Controls South Africa's Lenacapavir Rollout? Not South Africa AllAfrica 05:51 Wed, 22 Apr
South Africa: We Are Managing HIV With Selective Lenacapavir Roll-Out, Not Ending It AllAfrica 13:00 Mon, 20 Apr
How Investors Are Reacting To Gilead Sciences (GILD) Expanding No‑Profit Lenacapavir Access Globally Simply Wall St 18:41 Fri, 17 Apr
Lenacapavir and the Long Road from ‘Miracle’ to Global Access Observer Research Foundation 11:36 Thu, 16 Apr
US-Led Partnership To Provide 1 Mln Lenacapavir To Help End HIV Transmission RTT News 12:02 Wed, 15 Apr
The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance | The Futures Summit Center for Strategic and International Studies 22:29 Tue, 14 Apr
One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access Health Policy Watch 20:45 Tue, 14 Apr
United States-Led Partnership to Provide an Additional One Million People with Landmark American HIV Drug Lenacapavir to Help End Mother-to-Child HIV Transmission U.S Department of State 17:44 Tue, 14 Apr
Pepfar and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access Business Wire (Press Release) 17:08 Tue, 14 Apr
Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug Lenacapavir University of Manchester 13:33 Sat, 11 Apr
Lenacapavir rollout: US-South Africa collaboration strengthens fight against HIV Eyewitness News 18:45 Fri, 10 Apr
Motsoaledi hails Lenacapavir as game-changer for SA's fight against HIV/AIDS Eyewitness News 12:52 Wed, 08 Apr
Health Dept welcomes arrival of new HIV prevention medicine Lenacapavir Eyewitness News 05:12 Wed, 08 Apr
